Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry

QR Code

Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry

Background: Restenosis rates are low in large coronary vessels = 3.5 mm after bare-metal stent (BMS) implantation. The benefit of drug-eluting stents (DES) in large vessels is not established. Objective: We aim to assess clinical outcomes after deployment of BMS compared to DES in patients with larg...

Full description

Bibliographic Details
Main Authors:	Yan, B., Ajani, A., New, G., Duffy, S., Farouque, O., Shaw, J., Sebastian, M., Lew, R., Brennan, A., Andrianopoulos, N., Reid, Christopher, Clark, D.
Format:	Journal Article
Published:	Elsevier Ireland Ltd. 2008
Online Access:	http://hdl.handle.net/20.500.11937/39046

Similar Items

Long-term predictors of mortality after percutaneous coronary intervention in the era of drug-eluting stents
by: Wilson, W., et al.
Published: (2011)

Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents
by: Freeman, M., et al.
Published: (2009)

Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents
by: Shaw, J., et al.
Published: (2008)

Rates of Stent Thrombosis in Bare-Metal Versus Drug-Eluting Stents (from a Large Australian Multicenter Registry)
by: Yan, B., et al.
Published: (2008)

A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era
by: Ariyaratne, T., et al.
Published: (2016)

Recent trends in Australian percutaneous coronary intervention practice: Insights from the melbourne interventional group registry
by: Yan, B., et al.
Published: (2011)

Is there an obesity paradox after percutaneous coronary intervention in the contemporary era?: An analysis from a multicenter australian registry
by: Lancefield, T., et al.
Published: (2010)

Evolution of Australian Percutaneous Coronary Intervention (from the Melbourne Interventional Group [MIG] Registry)
by: Yeoh, J., et al.
Published: (2017)

IMPACT OF STENT DIAMETER ON OUTCOMES FOLLOWING PERCUTANEOUS CORONARY INTERVENTION WITH 2ND GENERATION DRUG ELUTING STENTS: RESULTS FROM A LARGE SINGLE-CENTER REGISTRY
by: Plitt, A., et al.
Published: (2018)

Long-term outcomes following percutaneous coronary intervention to an unprotected left main coronary artery in cardiogenic shock
by: Yeoh, J., et al.
Published: (2020)

Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes
by: Al-Fiadh, A., et al.
Published: (2011)

Impact of renal function in patients with multi-vessel coronary disease on long-term mortality following coronary artery bypass grafting compared with percutaneous coronary intervention
by: Sugumar, H., et al.
Published: (2014)

Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: Insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries
by: Yan, B., et al.
Published: (2009)

Clopidogrel, Prasugrel or Ticagrelor in Patients with Acute Coronary Syndromes undergoing Percutaneous Coronary Intervention.
by: Yudi, M., et al.
Published: (2016)

TemporalTrends of Heart Failure Patients Undergoing Percutaneous Coronary Intervention: Findings From Melbourne Interventional Group Registry
by: Chin, K., et al.
Published: (2017)

Long-term clinical outcomes of transient and persistent no-reflow following percutaneous coronary intervention (PCI): A multicentre Australian registry
by: Papapostolou, S., et al.
Published: (2018)

Impact of concomitant heart failure on outcomes in patients undergoing percutaneous coronary interventions: Analysis of the Melbourne Interventional Group registry
by: Lu, K., et al.
Published: (2011)

Early versus delayed percutaneous coronary intervention in patients with non-ST elevation acute coronary syndromes
by: Yudi, M., et al.
Published: (2016)

Does Statin Benefits Patients with Heart Failure Undergoing Percutaneous Coronary Intervention? Findings from the Melbourne Interventional Group Registry
by: Chin, K., et al.
Published: (2018)

Pretreatment with Dual Antiplatelet Therapy in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes undergoing Percutaneous Coronary Intervention
by: Yudi, M., et al.
Published: (2015)

Heart Rate as a Predictor of Outcome Following Percutaneous Coronary Intervention
by: O'Brien, J., et al.
Published: (2018)

Incidence, Predictors and Outcomes of Major Bleeding in Patients Following Percutaneous Coronary Interventions in Australia
by: Wlodarczyk, J., et al.
Published: (2015)

Temporal Changes in Characteristics, Treatment and Outcomes of Heart Failure Patients Undergoing Percutaneous Coronary Intervention Findings from Melbourne Interventional Group Registry
by: Chin, K., et al.
Published: (2018)

Totally Occluded Culprit Coronary Artery in Patients with Non-ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
by: Fernando, H., et al.
Published: (2021)

TCT-250 Long-term Clinical Outcomes of Transient and Persistent No-Reflow Following Percutaneous Coronary Intervention (PCI): Insights from a Multi-center Australian Registry.
by: Papapostolou, S., et al.
Published: (2016)

Cardiovascular readmissions and excess costs following percutaneous coronary intervention in patients with chronic kidney disease: Data from a large multi-centre Australian registry
by: Ariyaratne, T., et al.
Published: (2013)

Cardiovascular medication use following percutaneous coronary intervention: The Australian experience
by: Cole, J., et al.
Published: (2014)

Outcomes in patients with peripheral vascular disease following percutaneous coronary intervention
by: Ramzy, J., et al.
Published: (2019)

Incidence, Predictors and Clinical Outcomes of Stent Thrombosis Following Percutaneous Coronary Intervention in Contemporary Practice
by: Batchelor, R., et al.
Published: (2020)

Does the subtype of acute coronary syndrome treated by percutaneous coronary intervention predict long-term clinical outcomes?
by: Biswas, S., et al.
Published: (2018)

A PRACTICAL DEFINITION OF LATE STENT THROMBOSIS: INSIGHTS FROM THE MELBOURNE INTERVENTIONAL GROUP REGISTRY
by: Yan, B., et al.
Published: (2011)

Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention
by: Chan, W., et al.
Published: (2012)

Incidence and risk factors for stroke following percutaneous coronary intervention
by: Dawson, L.P., et al.
Published: (2020)

Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention
by: Chan, W., et al.
Published: (2012)

Establishment of a Percutaneous Coronary Intervention Registry in Vietnam: Rationale and Methodology
by: Vu, Hoa T. T., et al.
Published: (2020)

Clinical outcomes of drug-eluting stent use in patients with ST elevation myocardial infarction
by: Gurvitch, R., et al.
Published: (2010)

Survival of Elderly Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction Complicated by Cardiogenic Shock
by: Lim, H., et al.
Published: (2009)

Outcomes of Percutaneous Coronary Intervention in Patients With Rheumatoid Arthritis
by: Dawson, L.P., et al.
Published: (2021)

The prognostic significance of smoking cessation after acute coronary syndromes: An observational, multicentre study from the Melbourne interventional group registry
by: Yudi, M., et al.
Published: (2017)

PROLONGED EFFECTIVENESS OF CORONARY ARTERY BYPASS SURGERY VERSUS DRUG-ELUTING STENTS IN DIABETICS WITH MULTI-VESSEL DISEASE: AN UPDATED META-ANALYSIS
by: Ariyaratne, T., et al.
Published: (2012)